CONTACT US
Offices
Contact Form
Newsletter
CAREER
R&D PROJECTS
NEWS
MultiplexDX News
Publications
Press about MultiplexDX
PRODUCTS & SERVICES
COVID-19 Diagnostics
Custom Oligonucleotides
RNA Sequencing
RNA FISH
Bioinformatics
Personalized Diagnostics
MultiplexDX
Company overview
Innovations
Team
Clients
Achievements
NEWS
HOME
>
MultiplexDX News
Publications
Press about MultiplexDX
MultiplexDX News
Apr 2022
PRESS RELEASE
Áfram Ísland
Apr 2022
PRESS RELEASE
Design & development details of RT-PCR tests published
Jan 2022
PRESS RELEASE
As a challenging 2021 fades, new challenges lie ahead
Dec 2021
PRESS RELEASE
EIC Accelerator project to validate Multiplex8+ officially resumed
Sep 2021
PRESS RELEASE
The President of the Slovak Republic Zuzana Čaputová appreciated the contributions of dr. Čekan and MultiplexDX in the fight against COVID
Jun 2021
PRESS RELEASE
EC President Ursula von der Leyen visited the mobile LAMP-testing solution developed at MultiplexDX
Jun 2021
PRESS RELEASE
MultiplexDX Provided Testing at the International GLOBSEC 2021 Conference
Jun 2021
PRESS RELEASE
UK Minister Wendy Morton Visits MultiplexDX
Apr 2021
PRESS RELEASE
Súhrnná správa o zákazkách s nízkymi hodnotami nr.2
Mar 2021
PRESS RELEASE
Safe International IBU CUP in Osrblie-Brezno thanks to tests from MultiplexDX
Feb 2021
PRESS RELEASE
Nový LAMP-test prináša presnosť PCR-testov
Jan 2021
PRESS RELEASE
Slovenia uses MultiplexDX RT-qPCR tests to monitor the prevalence of the British SARS CoV-2 variant
Jan 2021
PRESS RELEASE
MultiplexDX to provide qPCR-tests to AGEL SK
Jan 2021
PRESS RELEASE
MultiplexDX oznámil úspešné dokončenie vývoja testu na britskú mutáciu SARS-CoV-2
Dec 2020
PRESS RELEASE
Humanitarian activities of MultiplexDX
Nov 2020
PRESS RELEASE
Business-academia cooperation in the Slovak innovation ecosystem during a global pandemic
Oct 2020
PRESS RELEASE
Breast Cancer Awareness Month
Oct 2020
PRESS RELEASE
CEWE donates a thousand tests for COVID-19 to Slovakia
Oct 2020
PRESS RELEASE
MultiplexDX daroval Slovenskej republike 100-tisíc testov na COVID-19
Oct 2020
PRESS RELEASE
GLOBSEC conference backed with MultiplexDX COVID-19 tests
Oct 2020
PRESS RELEASE
MultiplexDX receives funding for applied research on COVID/Influenza from the Slovak Research and Development Agency (APVV: PP-COVID 20 funding call)
Aug 2020
PRESS RELEASE
Tlačová správa: Slovensko výrazne obmedzilo bratislavských vedcov v čerpaní eurofondov určených na výskum COVID-19
Jun 2020
PRESS RELEASE
Spoločnosť MultiplexDX sa nesmierne teší zo spolupráce s CEWE
May 2020
PRESS RELEASE
MultiplexDX developed key components of the first Slovak IVD certified PCR diagnostic kit for COVID-19 financed by the ESET Foundation
Dec 2019
PRESS RELEASE
MultiplexDX Became a Proud Holder of the EIC Accelerator
Nov 2019
PRESS RELEASE
MultiplexDX Receives Slovak Ministry of Health Grant
Oct 2019
PRESS RELEASE
MultiplexDX moved their headquarters to Bratislava
Oct 2019
PRESS RELEASE
MultiplexDX received the best SME instrument phase 2 evaluation score among Slovak companies
Sep 2019
PRESS RELEASE
MultiplexDX expands their team
Sep 2019
PRESS RELEASE
MultiplexDX Receives IPA4SME Grant
Jul 2019
PRESS RELEASE
Súhrnná správa o zákazkách s nízkymi hodnotami nr.1
Jun 2019
PRESS RELEASE
MultiplexDX officially presented as a new member of Oslo Cancer Cluster in June 2019
Jun 2019
PRESS RELEASE
MultiplexDX joins the InvestHorizon Accelerator Programme
Apr 2019
PRESS RELEASE
CEO of MultiplexDX in his fireside chat at Startup Grind Bratislava
Mar 2019
PRESS RELEASE
CEO of MultiplexDX among speakers at 0100 Conference in Vienna
Mar 2019
PRESS RELEASE
MultiplexDX among the nominees for Ernst & Young (EY) Entrepreneur of The Year 2018 Award
Mar 2019
PRESS RELEASE
MultiplexDX hires new team members
Feb 2019
PRESS RELEASE
Another Horizon 2020 Seal of Excellence for MultiplexDX from European Commission
Jan 2019
PRESS RELEASE
CEO of MultiplexDX, Dr. Pavol Cekan, nominated for “Crystal Wing Awards”
Jan 2019
PRESS RELEASE
MultiplexDX Becomes a Member of the Prestigious Oslo Cancer Cluster
Dec 2018
PRESS RELEASE
Selected from the Best “Seal of Excellence” European Start-ups, MultiplexDX Gives a Pitch at Innovative Enterprise Vienna 2018
Oct 2018
PRESS RELEASE
MultiplexDX Wins CESAwards’ "Best Social Impact Startup" in the CEE Region
Oct 2018
PRESS RELEASE
MultiplexDX Applies for Patent to Secure its Revolutionary Technology
Oct 2018
PRESS RELEASE
MultiplexDX Receives €1,2 Million in Investments
Oct 2018
PRESS RELEASE
MultiplexDX Wins Three Central European Startup Awards
Oct 2018
PRESS RELEASE
MultiplexDX Receives €176 000 Grant from the Slovak Ministry of Education
Sep 2018
PRESS RELEASE
MultiplexDX Selected to Join Health Hub Vienna, One of Europe’s Premiere Accelerators
Sep 2018
PRESS RELEASE
MultiplexDX Wins Standard of Excellence Awards from the Web Marketing Association (WMA)
Jul 2018
PRESS RELEASE
MultiplexDX Was Awarded Horizon 2020 Seal of Excellence by the European Commission
Jul 2018
PRESS RELEASE
MultiplexDX Wins Prestigious JCI Creative Young Entrepreneur Award 2018
Feb 2018
PRESS RELEASE
MultiplexDX Is About to Close an Investment Round – Join Us
Dec 2017
PRESS RELEASE
Multiplex DX Was Listed in the New Europe 100: Eastern Europe’s Emerging Technology Star
Oct 2017
PRESS RELEASE
MultiplexDX Innovations. Unlocking the Full Potential of Personalized Cancer Diagnostics Through Multiplexed RNA-based Technologies.
Mar 2017
PRESS RELEASE
MultiplexDX Launches FullRNALook - the Simplest and Most Robust RNA FISH on the Market
Feb 2017
PRESS RELEASE
MultiplexDX Unveils Its Revolutionary Cancer Diagnostics Technology in a New Company Video
Dec 2016
PRESS RELEASE
MultiplexDX Becomes an Overall Winner of the Prestigious Startup Awards 2016
Publications
2022
Sequential development of several RT-qPCR tests using LNA nucleotides and dual probe technology to differentiate SARS-CoV-2 from influenza A and B
Microbial Biotechnology
2022
Surveillance of SARS-CoV-2 lineage B.1.1.7 in Slovakia using a novel, multiplexed RT-qPCR assay
Scientific Reports
2021
A novel, room temperature-stable, multiplexed RT-qPCR assay to distinguish lineageB.1.1.7 from the remaining SARS-CoV-2 lineages
MultiplexDX
2021
A non-radioactive, improved PAR-CLIP and small RNA cDNA library preparation protocol
Nucleic Acids Research
2014
Multiplexed miRNA Fluorescence In Situ Hybridization for Formalin-Fixed Paraffin-Embedded Tissues
Methods in Molecular Biology
2013
Multicolor microRNA FISH effectively differentiates tumor types
The Journal of Clinical Investigation
2009
Identification of Single-Base Mismatches in Duplex DNA by EPR Spectroscopy
Journal of the American Chemical Society
2009
Folding of the cocaine aptamer studied by EPR and fluorescence spectroscopies using the bifunctional spectroscopic probe C
Nucleic Acids Research
2009
Relative Orientation of Rigid Nitroxides by PELDOR: Beyond Distance Measurements in Nucleic Acids
Angewandte Chemie International Edition
2008
Rigid spin-labeled nucleoside C¸ : a nonperturbing EPR probe of nucleic acid conformation
Nucleic Acids Research
2008
Single base interrogation by a fluorescent nucleotide: each of the four DNA bases identified by fluorescence spectroscopy
Chemical Communications
2008
Inside Cover
Angewandte Chemie International Edition
Press about MultiplexDX
SK
Obrovské gesto Pavla Čekana: Odhalil detailný popis testov, postupy môže použiť akýkoľvek výrobca
March 2022
SK
Kapacity štátneho testovania sa zvýšiaAko zmeniť Slovensko na modernú krajinu? Radí dvanásť osobností. Nasadia nové LAMP testy
February 2022
SK
Kapacity štátneho testovania sa zvýšia. Nasadia nové LAMP testy
February 2022
SK
Čekan vyhral ďalší súdny spor s predstaviteľom Republiky. Dezinformátori rozpútali vojnu proti slovenským vedcom
January 2022
SK
Čekan si cení úspešnú spoluprácu s Biomedicínskym centrom SAV pri vývoji RT-PCR testov, odovzdal mu 339-tisíc eur
December 2021
SK
Slovenské PCR testy majú svetovú kvalitu a v skúške kvality obstáli na výbornú. Úspech mal aj nový rýchlotest
November 2021
SK
Slovenskí vedci zviditeľnili Slovensko vo svete
October 2021
SK
Prezidentka vyznamenala 24 osobností. Bol medzi nimi i Pavol Čekan CEO MultiplexDX.
June 2021
SK
Pavol Čekan ohúril Ursulu von der Leyenovú. Vďaka nej dnes pozná špičkové slovenské testy celá EÚ
June 2021
SK
Slovenskí vedci prišli s veľkým darom: Novinka v boji s KORONAVÍRUSOM! Preveria aj juhoafrický variant
March 2021
SK
Ako prví vo svete vyvinuli test na britskú mutáciu koronavírusu
January 2021
EN
Slovak tests distinguish between COVID-19 and flu
September 2020
SK
Tabuľa: Stručná biochémia C-19 a dizajn PCR testov
May 2020
SK
Pavol Čekan: Prvých stotisíc slovenských testov na koronavírus je pripravených, vydržia 40 dní
May 2020
SK
Korona testy od slovenských vedcov už majú certifikát. Prvých 100-tisíc kusov darujú štátu
May 2020
EN
Slovak-developed COVID-19 tests put to use
May 2020
SK
Biochemik Pavol Čekan: Zomkli sme sa. Nemusíme sa báť žiadnej krízy
Aril 2020
SK
Vedec, ktorý vyvíja slovenský test na koronavírus: Ich spoľahlivosť bude takmer stopercentná
April 2020
SK
Biochemik Čekan: Testy chceli kúpiť Maďari, ale pre nás je prvoradé Slovensko
April 2020
SK
ROZHOVOR: Vedec, ktorý stojí za prelomovými slovenskými testami na koronavírus
April 2020
SK
Biochemik Čekan vyvíja test na koronavírus: Vedci robia po nociach, dúfam, že sa na to po kríze nezabudne
April 2020
SK
Popredný biochemik Pavol Čekan: Slovenskí vedci nás teraz môžu zachrániť
April 2020
SK
Epidémie sme tu už mali. Možno sa konečne naučíme umývať si ruky a chrániť seba aj iných
March 2020
SK
Názor Pavla Čekana: 6 opatrení proti koronavírusu, ktoré musíme dodržať
March 2020
SK
Rozhovor s biotechnológom Palom Čekanom
February 2020
EN
MultiplexDX on Track to Launch New FISH, NGS-Based Breast Cancer Test by 2023
February 2020
SK
Rakovina má čiarový kód
February 2020
SK
Pavol Čekan: Ak mám tvoriť úspešný príbeh, tak na Slovensku
January 2020
SK
Biochemik Pavol Čekan: Slováci spresnia liečbu rakoviny
January 2020
SK
Vedec Čekan: Máme v rukách revolučnú technológiu, pomôže množstvu pacientov
December 2019
SK
Nová investícia do diagnostiky rakoviny. MultiplexDX získal 2,5 milióna eur
December 2019
SK
Zázraky na poli medicíny
June 2019
SK
Posun v liečbe rakoviny je neuveriteľný, stále je čo doháňať
December 2018
SK
Personalizovaná medicína v diagnostike rakoviny
April 2019
SK
Primárnou motiváciou je pacient
April 2019
SK
MultiplexDX — Best Social Impact Startup CESAwards 2018
February 2019
EN
MultiplexDX to End Cancer Misdiagnosis. How?
December 2018
SK
Miliónová investícia do diagnostiky rakoviny. Slovenský MultiplexDX dostal injekciu
September 2018
SK
Polovica pacientov dostáva podľa vedca chemoterapiu zbytočne. Vyvíjajú test, ktorý má odstrániť chyby pri diagnostike
July 2018
SK
Ocenili mladých podnikateľov. Ich nápady prerazili i za hranicami
July 2018
SK
Pavol Čekan vyvíja špičkový test na liečbu rakoviny. Blíži sa na trh
July 2018
SK
Personalizovaná diagnostika nesmie byť iba nejakým „ROLLS-ROYCEOM“
April 2018
SK
Portrét Pavla Čekana
February 2018
EN
Diagnostic tests that lead to personalized treatment
January 2018
SK
Slovák, ktorý patrí k svetovej špičke. Vyvíja unikátne metódy na boj s rakovinou
January 2018
SK
Startup MultiplexDX vyvíja diagnostické testy na liečbu nádorov
April 2017
SK
Biochemik Pavol Čekan: “Najväčší úspech slovenskej vedy je, že ešte stále tu je.”
October 2017
EN
Unlocking the Full Potential of Personalized Medicine through Multiplexed RNA-Based Technologies
September 2017
SK
Liečme lepšie rakovinu
February 2017
EN
Startup Awards 2016 Winners
December 2016
EN
Lighting up micro RNAs
2013
MultiplexDX NEWS
See all MultiplexDX clients
Receive Newsletter Updates
Thank you! Check your email shortly.
Oops! Something went wrong. Please check spelling or try later.